Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), is a liver disease worldwide without approved therapeutic drugs. Anti-inflammatory and hepatoprotective drug bicyclol and multi-pharmacological active drug berberine, respectively, have sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hu, Liu, Nan-Nan, Li, Jian-Rui, Dong, Biao, Wang, Mei-Xi, Tan, Jia-Li, Wang, Xue-Kai, Jiang, Jing, Lei, Lei, Li, Hong-Ying, Sun, Han, Jiang, Jian-Dong, Peng, Zong-Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889073/
https://www.ncbi.nlm.nih.gov/pubmed/35250593
http://dx.doi.org/10.3389/fphar.2022.843872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889073/
https://www.ncbi.nlm.nih.gov/pubmed/35250593
http://dx.doi.org/10.3389/fphar.2022.843872

Ejemplares similares